Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Role of Slow Waves in the Progression of Neurodegeneration in Isolated REM Sleep Behavior Disorder

Trial N/A Recruiting Feb. 16, 2026

Evaluation of the Safety of Electrical Spinal Cord Stimulation in Parkinson's Patients Presenting With Painful Camptocormia

Trial N/A Recruiting Feb. 16, 2026

Detection of Internal Tremors by Oscillometry in Parkinson's Patient

Trial N/A Recruiting Feb. 16, 2026

Social & QoL Behaviors in Parkinson's Disease

Trial N/A Recruiting Feb. 12, 2026

Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease

Trial N/A Recruiting Feb. 12, 2026

Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

Trial N/A Recruiting Feb. 12, 2026

Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease

Trial N/A Enrolling by invitation Feb. 12, 2026

DASH Diet, Triglycerides and AIP in Parkinson's Disease

Trial N/A Completed Feb. 11, 2026

Effects of Magnetic Stimulation of the Dorsal Spinal Cord on Gait in Patients With Parkinson´s Disease and Deep Brain Stimulation

Trial N/A Completed Feb. 11, 2026

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Trial N/A Recruiting Feb. 11, 2026

Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction

Trial N/A Recruiting Feb. 11, 2026

Intranasal Insulin in Parkinson's Disease

Trial Phase 2 Completed Feb. 10, 2026

Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease

Trial N/A Recruiting Feb. 10, 2026

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

Trial N/A Recruiting Feb. 10, 2026

Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease

Trial Phase 1 Not yet recruiting Feb. 10, 2026

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

Trial N/A Active, not recruiting Feb. 10, 2026

Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease

Trial N/A Recruiting Feb. 10, 2026

Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

Trial N/A Recruiting Feb. 10, 2026

Effects of Protective Step Training on Proactive and Reactive Motor Adaptations in Parkinson's Disease Patients

Trial N/A Completed Feb. 9, 2026

Expanded Access to Tavapadon

Trial N/A Available Feb. 9, 2026